Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Locke

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Mayo Clinic Proceedings|February 5, 2013
Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control studyCadman L Leggett, Eric M Nelsen, Jianmin Tian, et al.
Mayo Clinic Proceedings|December 3, 2011
Population screening for barrett esophagus: a prospective randomized pilot studyJoseph Y Chang, Nicholas J Talley, G Richard Locke, et al.
The American Journal of Gastroenterology|March 18, 2010
Familial aggregation of irritable bowel syndrome: a family case-control studyYuri A Saito, Gloria M Petersen, Joseph J Larson, et al.
The American Journal of Gastroenterology|June 18, 2003
A questionnaire for the assessment of biliary symptomsYvonne Romero, Johnson L Thistle, George F Longstreth, et al.
Gastrointestinal Endoscopy|November 22, 2007
Evaluation of endoscopic approaches for deep gastric-muscle-wall biopsies: what works?Elizabeth Rajan, Christopher J Gostout, Matthew S Lurken, et al.
The American Journal of Gastroenterology|April 13, 2011
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based studyKee Wook Jung, Nicholas J Talley, Yvonne Romero, et al.
Contemporary Clinical Trials|February 21, 2012
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogeneticsNicholas J Talley, G Richard Locke, Linda M Herrick, et al.
The American Journal of Gastroenterology|March 15, 2017
Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment TrialYuri A Saito, G Richard Locke, Ann E Almazar, et al.
Gastroenterology|April 30, 2015
Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled StudyNicholas J Talley, G Richard Locke, Yuri A Saito, et al.
Gastroenterology|March 12, 2014
Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndromeArthur Beyder, Amelia Mazzone, Peter R Strege, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Mayo Clinic Proceedings|February 5, 2013
Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control studyCadman L Leggett, Eric M Nelsen, Jianmin Tian, et al.
Mayo Clinic Proceedings|December 3, 2011
Population screening for barrett esophagus: a prospective randomized pilot studyJoseph Y Chang, Nicholas J Talley, G Richard Locke, et al.
The American Journal of Gastroenterology|March 18, 2010
Familial aggregation of irritable bowel syndrome: a family case-control studyYuri A Saito, Gloria M Petersen, Joseph J Larson, et al.
The American Journal of Gastroenterology|June 18, 2003
A questionnaire for the assessment of biliary symptomsYvonne Romero, Johnson L Thistle, George F Longstreth, et al.
Gastrointestinal Endoscopy|November 22, 2007
Evaluation of endoscopic approaches for deep gastric-muscle-wall biopsies: what works?Elizabeth Rajan, Christopher J Gostout, Matthew S Lurken, et al.
The American Journal of Gastroenterology|April 13, 2011
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based studyKee Wook Jung, Nicholas J Talley, Yvonne Romero, et al.
Contemporary Clinical Trials|February 21, 2012
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogeneticsNicholas J Talley, G Richard Locke, Linda M Herrick, et al.
The American Journal of Gastroenterology|March 15, 2017
Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment TrialYuri A Saito, G Richard Locke, Ann E Almazar, et al.
Gastroenterology|April 30, 2015
Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled StudyNicholas J Talley, G Richard Locke, Yuri A Saito, et al.
Gastroenterology|March 12, 2014
Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndromeArthur Beyder, Amelia Mazzone, Peter R Strege, et al.
Pageof 11